LOXL1 and Polypoidal choroidal vasculopathy: The role of the LOXL1 polymorphism has been tested in several pathologies including wet and dry age-related macular degeneration and polypoidal choroidal vasculopathy in a Japanese population [24], Alzheimer disease in a Swedish population [25], and cardiovascular disease in a Hungarian population [26].